ACOG practice bulletin No. 97: Fetal lung maturity

Obstetrics and Gynecology

Volumn 112, Issue 3, 2008, Pages 717-726

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BETAMETHASONE; CHORIONIC GONADOTROPIN; LUNG SURFACTANT; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPID; SPHINGOMYELIN;

AMNIOCENTESIS; AMNION FLUID; ANTHROPOMETRIC PARAMETERS; BRAIN HEMORRHAGE; CESAREAN SECTION; DOPPLER ECHOGRAPHY; FETAL HEMORRHAGE; FETUS ECHOGRAPHY; FETUS HEART RATE; FETUS LUNG MATURATION; FETUS LUNG MATURITY; FETUS MATURITY; FIRST TRIMESTER PREGNANCY; FLUORESCENCE POLARIZATION; GESTATIONAL AGE; HEART ARRHYTHMIA; HUMAN; HYDRAMNIOS; IMMATURITY; LAMELLAR BODY; LECITHIN SPHINGOMYELIN RATIO; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS SURFACE TENSION; LUNG COLLAPSE; LUNG DEVELOPMENT; LUNG FUNCTION; LUNG FUNCTION TEST; MECONIUM ASPIRATION; NECROTIZING ENTEROCOLITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN ASSESSMENT; NEWBORN HYPOXIA; OLIGOHYDRAMNIOS; PATENT DUCTUS ARTERIOSUS; PATHOPHYSIOLOGY; PREGNANCY DIABETES MELLITUS; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; SECOND TRIMESTER PREGNANCY; SOLUTIO PLACENTAE; THIN LAYER CHROMATOGRAPHY; THIRD TRIMESTER PREGNANCY; TWIN PREGNANCY; UTERUS RUPTURE; ARTICLE; FEMALE; LUNG; NEWBORN; PRACTICE GUIDELINE; PREGNANCY; PRENATAL DEVELOPMENT;

AMNIOCENTESIS; FEMALE; FETAL ORGAN MATURITY; HUMANS; INFANT, NEWBORN; LUNG; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 55949089465     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e318188d1c2     Document Type: Review

References (44)

1. Wigton TR, Tamura RK, Wickstrom E, Atkins V, Deddish R, Socol ML. Neonatal morbidity after preterm delivery in the presence of documented lung maturity. Am J Obstet Gynecol 1993;169:951-5. (Level III)
2. Ghidini A, Hicks C, Lapinski RH, Lockwood CJ. Morbidity in the preterm infant with mature lung indices. Am J Perinatol 1997;14:75-8. (Level II-3)
3. Zanardo V, Simbi AK, Franzoi M, Solda G, Salvadori A, Trevisanuto D. Neonatal respiratory morbidity risk and mode of delivery at term: influence of timing of elective caesarean delivery. Acta Paediatr 2004;93:643-7. (Level II-2)
4. Neerhof MG, Haney EI, Silver RK, Ashwood ER, Lee IS, Piazze JJ. Lamellar body counts compared with traditional phospholipid analysis as an assay for evaluating fetal lung maturity. Obstet Gynecol 2001;97:305-9. (Level II-3)
5. Haymond S, Luzzi VI, Parvin CA, Gronowski AM. A direct comparison between lamellar body counts and fluorescent polarization methods for predicting respiratory distress syndrome. Am J Clin Pathol 2006;126:894-9. (Level II-3)
6. Winn-McMillan T, Karon BS. Comparison of the TDx-FLM II and lecithin to sphingomyelin ratio assays in predicting fetal lung maturity. Am J Obstet Gynecol 2005; 193:778-82. (Level II-3)
7. Karcher R, Sykes E, Batton D, Uddin Z, Ross G, Hockman E, et al. Gestational age-specific predicted risk of neonatal respiratory distress syndrome using lamellar body count and surfactant-to-albumin ratio in amniotic fluid. Am J Obstet Gynecol 2005;193:1680-4. (Level II-3)
8. Parvin CA, Kaplan LA, Chapman JF, McManamon TG, Gronowski AM. Predicting respiratory distress syndrome using gestational age and fetal lung maturity by fluorescent polarization. Am J Obstet Gynecol 2005;192: 199-207. (Level III)
9. Pinette MG, Blackstone J, Wax JR, Cartin A. Fetal lung maturity indices - a plea for gestational age-specific interpretation: a case report and discussion. Am J Obstet Gynecol 2002;187:1721-2. (Level III)
10. Kesselman EJ, Figueroa R, Garry D, Maulik D. The usefulness of the TDx/TDxFLx fetal lung maturity II assay in the initial evaluation of fetal lung maturity. Am J Obstet Gynecol 2003;188:1220-2. (Level II-3)
11. Fantz CR, Powell C, Karon B, Parvin CA, Hankins K, Dayal M, et al. Assessment of the diagnostic accuracy of the TDx-FLM II to predict fetal lung maturity. Clin Chem 2002;48:761-5. (Level II-3)
12. Field NT, Gilbert WM. Current status of amniotic fluid tests of fetal maturity. Clin Obstet Gynecol 1997;40: 366-86. (Level III)
13. Ventolini G, Neiger R, Hood DL, Belcastro MR. Changes in the threshold of fetal lung maturity testing and neonatal outcome of infants delivered electively before 39 weeks gestation: implications and cost-effectiveness. J Perinatol 2006;26:264-7. (Level II-3)
14. Khazardoost S, Yahyazadeh H, Borna S, Sohrabvand F, Yahyazadeh N, Amini E. Amniotic fluid lamellar body count and its sensitivity and specificity in evaluating of fetal lung maturity. J Obstet Gynaecol 2005;25:257-9. (Level II-3)
15. Torday JS, Rehan VK. Testing for fetal lung maturation: a biochemical "window" to the developing fetus. Clin Lab Med 2003;23:361-83. (Level III)
16. Kaplan LA, Chapman JF, Bock JL, Santa Maria E, Clejan S, Huddleston DJ, et al. Prediction of respiratory distress syndrome using the Abbott FLM-II amniotic fluid assay. Clin Chim Acta 2002;326:61-8. (Level III)
17. Melanson SE, Jarolim P, McElrath TF, Berg A, Tanasijevic MJ. Fetal lung maturity testing in diabetic mothers. Lab Med 2007;38:553-5. (Level III)
18. Gordon MC, Narula K, O'Shaughnessy R, Barth WH Jr. Complications of third-trimester amniocentesis using continuous ultrasound guidance. Obstet Gynecol 2002;99: 255-9. (Level II-3)
19. Stark CM, Smith RS, Lagrandeur RM, Batton DG, Lorenz RP. Need for urgent delivery after third-trimester amniocentesis. Obstet Gynecol 2000;95:48-50. (Level II-3)
20. Farrell PM, Engle MJ, Zachman RD, Curet LB, Morrison JC, Rao AV, et al. Amniotic fluid phospholipids after maternal administration of dexamethasone. Am J Obstet Gynecol 1983;145:484-90. (Level II-2)
21. Piazze JJ, Maranghi L, Nigro G, Rizzo G, Cosmi E V, Anceschi MM. The effect of glucocorticoid therapy on fetal lung maturity indices in hypertensive pregnancies. Obstet Gynecol 1998;92:220-5. (Level II-2)
22. Leveno KJ, Quirk JG, Whalley PJ, Herbert WN, Trubey R. Fetal lung maturation in twin gestation. Am J Obstet Gynecol 1984;148:405-11. (Level III)
23. McElrath TF, Norwitz ER, Robinson JN, Tanasijevic MJ, Lieberman ES. Differences in TDx fetal lung maturity assay values between twin and singleton gestations. Am J Obstet Gynecol 2000;182:1110-2. (Level II-3)
24. Winn HN, Romero R, Roberts A, Liu H, Hobbins JC. Comparison of fetal lung maturation in preterm singleton and twin pregnancies. Am J Perinatol 1992;9:326-8. (Level II-3)
25. Spellacy WN, Cruz AC, Buhi WC, Birk SA. Amniotic fluid L/S ratio in twin gestation. Obstet Gynecol 1977;50:68-70. (Level II-3)
26. Whitworth NS, Magann EF, Morrison JC. Evaluation of fetal lung maturity in diamniotic twins. Am J Obstet Gynecol 1999;180:1438-41. (Level II-3)
27. Mackenzie MW. Predicting concordance of biochemical lung maturity in the preterm twin gestation. J Matern Fetal Neonatal Med 2002;12:50-8. (Level II-3)
28. Chasen ST, Madden A, Chervenak FA. Cesarean delivery of twins and neonatal respiratory disorders. Am J Obstet Gynecol 1999;181:1052-6. (Level II-3)
29. Piazze JJ, Maranghi L, Cosmi EV, Anceschi MM. The effect of polyhydramnios and oligohydramnios on fetal lung maturity indexes. Am J Perinatol 1998;15:249-52. (Level II-2)
30. Edwards RK, Duff P, Ross KC. Amniotic fluid indices of fetal pulmonary maturity with preterm premature rupture of membranes. Obstet Gynecol 2000;96:102-5. (Level II-3)
31. Cleary-Goldman J, Connolly T, Chelmow D, Malone F. Accuracy of the TDx-FLM assay of amniotic fluid: a comparison of vaginal pool samples with amniocentesis. J Matern Fetal Neonatal Med 2002;11:374-7. (Level II-3)
32. Carlan SJ, Gearity D, O'Brien WF. The effect of maternal blood contamination on the TDx-FLM II assay. Am J Perinatol 1997;14:491-4. (Level III)
33. Livingston EG, Herbert WN, Hage ML, Chapman JF, Stubbs TM. Use of the TDx-FLM assay in evaluating fetal lung maturity in an insulin-dependent diabetic population. The Diabetes and Fetal Maturity Study Group. Obstet Gynecol 1995;86:826-9. (Level II-3)
34. Del Valle GO, Adair CD, Ramos EE, Gaudier FL, Sanchez-Ramos L, Morales R. Interpretation of the TDx-FLM fluorescence polarization assay in pregnancies complicated by diabetes mellitus. Am J Perinatol 1997;14:241-4. (Level II-3)
35. Curet LB, Tsao FH, Zachman RD, Olson RW, Henderson PA. Phosphatidylglycerol, lecithin/sphingomyelin ratio and respiratory distress syndrome in diabetic and non-diabetic pregnancies. Int J Gynaecol Obstet 1989;30: 105-8. (Level II-2)
36. Langer O. The controversy surrounding fetal lung maturity in diabetes in pregnancy: a re-evaluation. J Matern Fetal Neonatal Med 2002;12:428-32. (Level III)
37. Piper JM, Xenakis EM, Langer O. Delayed appearance of pulmonary maturation markers is associated with poor glucose control in diabetic pregnancies. J Matern Fetal Med 1998;7:148-53. (Level II-2)
38. Moore TR. A comparison of amniotic fluid fetal pulmonary phospholipids in normal and diabetic pregnancy. Am J Obstet Gynecol 2002;186:641-50. (Level II-2)
39. Piper JM, Langer O. Does maternal diabetes delay fetal pulmonary maturity? Am J Obstet Gynecol 1993;168: 783-6. (Level II-2)
40. Berkowitz K, Reyes C, Saadat P, Kjos SL. Fetal lung maturation. Comparison of biochemical indices in gestational diabetic and nondiabetic pregnancies. J Reprod Med 1997;42:793-800. (Level II-2)
41. Piazze JJ, Anceschi MM, Maranghi L, Brancato V, Marchiani E, Cosmi E V. Fetal lung maturity in pregnancies complicated by insulin-dependent and gestational diabetes: a matched cohort study. Eur J Obstet Gynecol Reprod Biol 1999;83:145-50. (Level II-2)
42. Piper JM. Lung maturation in diabetes in pregnancy: if and when to test. Semin Perinatol 2002;26:206-9. (Level III)
43. Burkhart AE, Towers CV, Rumney PJ, Lewis DF. Neonatal outcome when delivery follows a borderline immature lecithin to sphingomyelin ratio. J Perinatol 2000;20:157-60. (Level III)
44. Bildirici I, Moga CN, Gronowski AM, Sadovsky Y. The mean weekly increment of amniotic fluid TDx-FLM II ratio is constant during the latter part of pregnancy. Am J Obstet Gynecol 2005;193:1685-90. (Level III)